Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 1
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality?
Zagidullin NS, Motloch LJ, Musin TI, Bagmanova ZA, Lakman IA, Tyurin AV, Gumerov RM, Enikeev D, Cai B, Gareeva DF, Davtyan PA, Gareev DA, Talipova HM, Badykov MR, Jirak P, Kopp K, Hoppe UC, Pistulli R, Pavlov VN. Zagidullin NS, et al. Among authors: gareeva df. PLoS One. 2021 Oct 14;16(10):e0257982. doi: 10.1371/journal.pone.0257982. eCollection 2021. PLoS One. 2021. PMID: 34648510 Free PMC article.
Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 Pneumonia.
Motloch LJ, Jirak P, Gareeva D, Davtyan P, Gumerov R, Lakman I, Tataurov A, Zulkarneev R, Kabirov I, Cai B, Valeev B, Pavlov V, Kopp K, Hoppe UC, Lichtenauer M, Fiedler L, Pistulli R, Zagidullin N. Motloch LJ, et al. Among authors: gareeva d. Front Med (Lausanne). 2022 Jun 28;9:906665. doi: 10.3389/fmed.2022.906665. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35836945 Free PMC article.
Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors.
Motloch LJ, Jirak P, Mirna M, Fiedler L, Davtyan PA, Lakman IA, Gareeva DF, Tyurin AV, Gumerov RM, Matskeplishvili ST, Pavlov VN, Cai B, Kopp K, Topf A, Hoppe UC, Pistulli R, Zagidullin NS. Motloch LJ, et al. Among authors: gareeva df. Front Cardiovasc Med. 2022 Jul 29;9:916156. doi: 10.3389/fcvm.2022.916156. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35966512 Free PMC article.
Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 Pneumonia.
Fiedler L, Motloch LJ, Jirak P, Gumerov R, Davtyan P, Gareeva D, Lakman I, Tataurov A, Lasinova G, Pavlov V, Hauptmann L, Kopp K, Hoppe UC, Lichtenauer M, Pistulli R, Dieplinger AM, Zagidullin N. Fiedler L, et al. Among authors: gareeva d. Biomedicines. 2022 Nov 10;10(11):2889. doi: 10.3390/biomedicines10112889. Biomedicines. 2022. PMID: 36359409 Free PMC article.
Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors.
Fiedler L, Motloch LJ, Dieplinger AM, Jirak P, Davtyan P, Gareeva D, Badykova E, Badykov M, Lakman I, Agapitov A, Sadikova L, Pavlov V, Föttinger F, Mirna M, Kopp K, Hoppe UC, Pistulli R, Cai B, Yang B, Zagidullin N. Fiedler L, et al. Among authors: gareeva d. Front Pharmacol. 2023 May 30;14:1093396. doi: 10.3389/fphar.2023.1093396. eCollection 2023. Front Pharmacol. 2023. PMID: 37324463 Free PMC article.
Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction.
Zagidullin N, Motloch LJ, Gareeva D, Hamitova A, Lakman I, Krioni I, Popov D, Zulkarneev R, Paar V, Kopp K, Jirak P, Ishmetov V, Hoppe UC, Tulbaev E, Pavlov V. Zagidullin N, et al. Among authors: gareeva d. J Clin Med. 2020 Feb 18;9(2):550. doi: 10.3390/jcm9020550. J Clin Med. 2020. PMID: 32085400 Free PMC article.